sk&f 82958 has been researched along with lithium chloride in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agam, G; Belmaker, RH; Heldman, E; Mann, L; Shaltiel, G | 1 |
Foreman, MM; Hanania, T; Malekiani, SA; Olivier, B; Paterson, NE | 1 |
2 other study(ies) available for sk&f 82958 and lithium chloride
Article | Year |
---|---|
Lithium preferentially inhibits adenylyl cyclase V and VII isoforms.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Benzazepines; Calcimycin; Cells, Cultured; Chlorocebus aethiops; Colforsin; COS Cells; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Enzyme Inhibitors; Isoenzymes; Lithium Chloride; Plasmids; Receptors, Dopamine D1; Signal Transduction; Substrate Specificity; Sulpiride; Transfection | 2008 |
Pharmacological characterization of harmaline-induced tremor activity in mice.
Topics: Affect; Animals; Anticonvulsants; Baclofen; Behavior, Animal; Benzazepines; Carbolines; Chlordiazepoxide; Dopamine; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Glutamates; Harmaline; Lithium Chloride; Male; Mice; Mice, Inbred ICR; Muscimol; Neurotransmitter Agents; Piperazines; Propranolol; Raclopride; Receptors, Glutamate; Sodium Oxybate; Tremor | 2009 |